47mon MSN
Corona Remedies IPO day 2: GMP holds strong despite a mild dip; issue subscribed 62%. Did you apply?
Corona Remedies’ Rs 655-crore IPO entered Day 2 after achieving 62% subscription on Day 1, driven largely by retail demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results